Daiwa Securities Group
AKCA

Daiwa Securities Group’s Akcea Therapeutics Inc AKCA Stock Holding History

Daiwa Securities Group’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-578
Closed -$10K – 1316
2020
Q3 		$10K Buy
578
+48
+9% +$681 ﹤0.01% 1041
2020
Q2 		$8K Hold
530
– – ﹤0.01% 1084
2020
Q1 		$8K Hold
530
– – ﹤0.01% 1077
2019
Q4 		$9K Sell
530
-63
-11% -$1.17K ﹤0.01% 1078
2019
Q3 		$9K Buy
593
+25
+4% +$533 ﹤0.01% 1041
2019
Q2 		$13K Hold
568
– – ﹤0.01% 1043
2019
Q1 		$16K Sell
568
-100
-15% -$2.91K ﹤0.01% 1003
2018
Q4 		$20K Buy
668
+300
+82% +$8.41K ﹤0.01% 968
2018
Q3 		$13K Hold
368
– – ﹤0.01% 1021
2018
Q2 		$9K Hold
368
– – ﹤0.01% 1062
2018
Q1 		$9K Buy
+368
New +$7.92K ﹤0.01% 1043

Daiwa Securities Group's AKCA Position: Q4 2020 in Review

Daiwa Securities Group sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 578 shares — an estimated $10K sold.

Daiwa Securities Group first reported a position in AKCA in Q1 2018 and held it in 11 quarters. The position peaked at $20K in Q4 2018. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Daiwa Securities Group reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Daiwa Securities Group sold 578 Akcea Therapeutics Inc shares in Q4 2020, an estimated $10K.
  • Daiwa Securities Group first reported a position in Akcea Therapeutics Inc in Q1 2018 and held it in 11 quarters.
  • Daiwa Securities Group's Akcea Therapeutics Inc position peaked at $20K in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.